[1891]
Hepatosplenic ?d T-cell lymphoma associated with hepatitis B ...
From [medical.med.tokushima-u.ac.jp] Last viewed: 13.07.2004
[1892]
Primary Adrenal lymphoma presented with adrenal insufficiency
From [www.endocrine-society.gr] Last viewed: 13.07.2004
6 8
E. DIAMANTI-KANDARAKIS, ET AL
HORMONES 2004, 3(1):68-73
Case Report
Primary Adrenal lymphoma presented with adrenal
insufficiency
Evanthia Diamanti-Kandarakis
1
, Pantelis Chatzismalis
1
, Frangiskos Economou
1
,
Stefanos Lazarides
1
, Athena Androulaki
2
, Grigorios Kouraklis
3
1
Endocrine Section, First Department of Medicine, Athens University Medical School,
2
Department of Pathology,
Laiko General Hospital,
3
2
nd
Department of Surgery Athens University Medical School, Athens, Greece
ABSTRACT
We report a 71-year old man who presented with symptoms of adrenal insufficiency and large
bilateral adrenal masses. Computed tomography guided FNA biopsy was not diagnostic. However,
because of the rapid growth of the masses, ...
[1893]
Primary Central Nervous System Lymphoma
From [www.uveitissociety.org] Last viewed: 13.07.2004
Primary Central Nervous System Lymphoma
A Patient Education Monograph prepared for the American Uveitis Society
January 2003
by Justine R. Smith, MBBS, PhD
Assistant Professor
Casey Eye Institute
Oregon Health & Sciences University
NOTE: The opinions expressed in this monograph are those of the author(s) and not necessarily
those of the membership of the American Uveitis Society, its leadership, or the Editorial Board
of UveitisSociety.org. All medical decisions should be made in consultation with one’s personal
physician.
Introduction
Primary central nervous system (CNS) lymphoma is a rare cancer that involves the central
nervous system (brain, spinal cord, one or both eyes, and/or the coverings of the brain and optic
nerve, also known as the meninges). The designation as a " lymphoma " reflects the fact that the
cancerous cells are lymphocytes, a type of white ...
[1894]
Answer and comments: Primary central nervous system (CNS) ...
From [www.jsnm.org] Last viewed: 13.07.2004
[1895]
ASU ID 993755974 Follicular non-Hodgkin’s lymphoma (NHL) is an ...
From [www.public.asu.edu] Last viewed: 13.07.2004
COMPUTATIONAL MOLECULAR BIOLOGY
HOMEWORK 2
SHUBHRA GUPTA
ASU ID 993755974
Follicular non-Hodgkin’s lymphoma (NHL) is an indolent B cell malignancy with an
annual incidence exceeding 10,000 cases in the United States.
Rituximab, a chimeric IgG1 monoclonal antibody directed at the B cell antigen.
Column and row represent:
Each row represents a particular cDNA and each column is an individual follicular
lymphoma (FL) or normal lymphoid tissue sample.
CLID : Clone id
FL1_CR_LC: follicular lymphoma (patient number)_complete response_lymphochip
microarrays
FL1_NR_LC: follicular lymphoma (patient number)_no response_lymphochip
microarrays
FL1_PR_LC: follicular lymphoma (patient number)_partial response_lymphochip
microarrays
GWEIGHT (gene weight) and EWEIGHT (experiment weight)
Name: clone identifier
IMAGE and LCP: clone name or ...
[1896]
Identification of Apoptosis-associated Proteins in a Human Burkitt ...
From [fg-doerken.mdh2.mdc-berlin.de] Last viewed: 13.07.2004
Identification of Apoptosis-associated Proteins in a Human Burkitt
Lymphoma Cell Line
CLEAVAGE OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1 BY CASPASE 3*
(Received for publication, June 2, 1998, and in revised form, July 30, 1998)
Ekkehard Brockstedt‡§, Anke Rickers§
¶
, Susanne Kostka‡, Andreas Laubersheimer
¶
,
Bernd Do
¨ rken
¶
, Brigitte Wittmann-Liebold‡**, Kurt Bommert
¶
, and Albrecht Otto‡
From ‡ Proteinchemie and
¶
Medizinische Onkologie und Tumorimmunologie, Max-Delbru
¨ ck-Centrum fu
¨ r Molekulare
Medizin, Robert-Ro¨ssle-Straße 10 and Charite´, Humboldt University of Berlin, Robert Ro¨ssle Klinik,
D-13125 Berlin, Germany
Apoptosis or programmed cell death is essential in the
process of controlling lymphocyte growth and selection.
We identified ...
[1897]
ALK (Anaplastic Lymphoma Kinase) p80
From [www.labvision.com] Last viewed: 13.07.2004
D
ATA
S
HEET
Rev 021803B
ALK (Anaplastic Lymphoma Kinase) p80
Epitope Specific Rabbit Antibody
Cat. #RB-9001-P0, -P1, or -P (0.1ml, 0.5ml, or 1.0ml at 200µg/ml) (Purified Ab with BSA and Azide)
Cat. #RB-9001-R7 (7.0ml) (Ready-to-Use for Immunohistochemical Staining)
Cat. #RB-9001-PCS (5 Slides) (Positive Control for Histology)
#&&( ÃXrvtu?rÃ9? ÃA?r?Ã86ÃÃ(#$"(ÃVT6Ã
Ury)Ã ' Ã'!' %!'ÃÃAh?)Ã $ Ã(( !'!%Ã
@?hvy)Ãyhi?v?v?5yhi?v?v? pÃÃXri?v?r)Ã yhi?v?v? p
Description:
Recognizes a human p80 protein, identified as a
hybrid of the anaplastic lymphoma kinase (ALK)
gene and the nucleophosmin (NPM) gene resulting
from the t(2;5)(p23;q35) translocation found in a
third of large cell lymphomas. This rebbit polyclonal
antibody can be used to detect p80 in these
lymphomas and may also be used ...
[1898]
Patient Intake Process for Lymphoma/Leukemia Patients Referred to ...
From [www.lrcc.on.ca] Last viewed: 13.07.2004
[1899]
Orbital Lymphoma: Results of Radiation Therapy
From [annals.edu.sg] Last viewed: 13.07.2004
474
Annals Academy of Medicine
Orbital Lymphoma Treated with Radiotherapy—H Y Lau et al
Orbital Lymphoma : Results of Radiation Therapy
H Y Lau,*
MD, FRCP (Canada)
, E T Chua,**
FAMS, MBBS, FRCR
, T L Yang,***
FAMS, MBBS, FRCR
, E J Chua,****
FAMS, MD, DMRT
Abstract
Orbital lymphoma is a rare presentation of non-Hodgkin’s lymphoma . Treatment with radiotherapy is well-established. Twenty
cases of orbital lymphoma treated at the Singapore General Hospital with radiation therapy were reviewed. All patients had improvement
of their initial presenting symptoms and complete remission after radiation. Long-term local control was achieved in 17 of 20 (85%) of the
treated orbits.
Ann Acad Med Singapore 1998; 27:474-7
Key words: Eye, Non-Hodgkin’s lymphoma , Orbit, Radiotherapy
* Senior ...
[1900]
Daniel J. Medina, PhD Lymphoma Vaccine Development
From [www.state.nj.us] Last viewed: 13.07.2004
Daniel J. Medina, PhD
Lymphoma Vaccine Development
[We will modify cells from patients with non-Hodgkin’s lymphoma or chronic
lymphocytic leukemia so that they will be recognized by their immune system and
rejected.]
Many patients with non-Hodgkin’s lymphoma or chronic lymphocytic leukemia can not
be cured with chemotherapy. Treatment for those patients must incorporate novel
therapies. This proposal describes pre-clinical studies designed to develop therapeutic
vaccine for these patients. The approach will be to entice the malignant cell to change its
surface so that it will be recognized by the immune system and rejected. We will obtain
malignant cells from patients and manipulate the cells in the laboratory. We will study a
variety of manipulations and select those anticipated to make the malignant cell most
recognizable by the immune system. We will then test the capacity of these ...
[1901]
International and Italian prognostic indices in follicular ...
From [www.haematologica.org] Last viewed: 13.07.2004
Daniel J. Medina, PhD
Lymphoma Vaccine Development
[We will modify cells from patients with non-Hodgkin’s lymphoma or chronic
lymphocytic leukemia so that they will be recognized by their immune system and
rejected.]
Many patients with non-Hodgkin’s lymphoma or chronic lymphocytic leukemia can not
be cured with chemotherapy. Treatment for those patients must incorporate novel
therapies. This proposal describes pre-clinical studies designed to develop therapeutic
vaccine for these patients. The approach will be to entice the malignant cell to change its
surface so that it will be recognized by the immune system and rejected. We will obtain
malignant cells from patients and manipulate the cells in the laboratory. We will study a
variety of manipulations and select those anticipated to make the malignant cell most
recognizable by the immune system. We will then test the capacity of these ...
[1902]
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
From [usagiedu.com] Last viewed: 13.07.2004
Gastric Mucosa-Associated Lymphoid Tissue
Lymphoma
Asyia Ahmad, M.D., Yogesh Govil, M.D., MRCP (UK), and Barbara B. Frank, M.D.
Division of Gastroenterology and Hepatology, Drexel University, and Graduate Hospital,
Philadelphia, Pennsylvania
ABSTRACT
The connection between Helicobacter pylori and gastric
mucosa-associated lymphoid tissue (MALT) lymphoma is
well established. H. pylori infection causes an immunolog-
ical response, leading to chronic gastritis with formation of
lymphoid follicles within the stomach. These lymphoid fol-
licles resemble nodal tissues found throughout the body and
are composed of reactive T cells and activated plasmal cells
and B cells. The B cells are responsible for initiating a clonal
expansion of centrocyte-like cells that form the basic his-
tology of MALT lymphoma . Early diagnosis of MALT
lymphoma is difficult but essential for adequate ...
[1903]
MEET THE EXPERT ON NON-HODGKIN LYMPHOMA:
From [www.cancereducation.com] Last viewed: 13.07.2004
1
MEET THE EXPERT ON NON-HODGKIN LYMPHOMA :
N
E W
I
N S I G H T S A N D
T
R E AT M E N T S
MS. BANACKY:
My name is Illona Banacky. I was diagnosed with non-Hodgkin lymphoma on
November 13, 2003. At the time, my doctor explained that there were a few
options available. These included chemotherapy through pills or intravenous
therapy, and the most aggressive would be stem cell transplant.
When I first diagnosed, I think I went into treatment too quickly. I think before
you even opt to go into immediate treatment, do the research first and make sure
that you’re comfortable with the doctor and the facility where you are being
treated. I think it was important that the doctor and everyone around me —
family, friends — understood what I was going through, not just emotionally, but
also the treatment options, and helped me decide which road ...
[1904]
Acquired Immunodeficiency Syndrome Presenting as Childhood Non ...
From [www.sma.org.sg] Last viewed: 13.07.2004
Acquired Immunodeficiency
Syndrome Presenting as Childhood
Non-Hodgkin’s Lymphoma
W S Lee, T L Chan, M T Koh, W A Ariffin, H P Lin
Department of
Paediatrics
University of Malaya
Medical Centre
59100 Kuala Lumpur
Malaysia
W S Lee, MRCP (UK)
Associate Professor
T L Chan,
MBBS (Malaya)
Lecturer
M T Koh, FRCP (Edin)
Associate Professor
W A Ariffin,
FRCP (Edin)
Professor
H P Lin, FRACP
Professor
Correspondence to:
Dr Lee Way Seah
Tel: (603) 7950 2065
Fax: (603) 7955 6114
Email: leews@
ummc.edu.my
Singapore Med J 2001 Vol 42(11) : 530-533
C a s e R e p o r t
ABSTRACT
Two children with non-Hodgkin’s lymphoma (NHL)
as the presenting illness of acquired immunodeficiency
syndrome (AIDS) are described. There was a delay
in diagnosing the underlying AIDS in both ...
[1905]
Antiepileptic Treatment and Risk for Hepatobiliary Cancer and ...
From [dceg2.cancer.gov] Last viewed: 13.07.2004
[CANCER RESEARCH 55, 294-297, January 15, 1995]
Antiepileptic Treatment and Risk for Hepatobiliary Cancer
and Malignant Lymphoma
Jørgen H. Olsen,
1
Gabi Schulgen, John D. Boice, Jr., John Whysner, Lois B. Travis, Gary M. Williams,
Frank B. Johnson, and James 0'D. McGee
Division for Cancer Epidemiology, Danish Cancer Society, DK-2100 Copenhagen Ø, Denmark [J. H. O.]; Institut für Medizinische Biometric and Informatik der Albert Ludwigs
Universität Freiburg, D-79104 Freiburg, Germany [G. S.]: Radiation Epidemiology Branch National Cancer Institute, Bethesda, Maryland 20892 [J. D. B., L B. T.]; Division of
Pathology and Toxicology, American Health Foundation,
Valhalla, New York 10595 [J. W., G, M. W.]; Department of Cheemical Pathology, Armed Forces Institute of Pathology,
Washington, DC [F. B. J.]: and Nuffield Department of Pathology and Bacteriology, John Radcliff Hospital ...
[1906]
Summary A Case of Orbital MALT Lymphoma in which Ga Scintigraphy ...
From [www.jsnm.org] Last viewed: 13.07.2004
Summary
A Case of Orbital MALT Lymphoma in which
67
Ga Scintigraphy was Useful
for Evaluating the Radiation Therapy Response
Toru T
AKESHITA
*, Tatsuro K
AMINAGA
*, Shigeru F
URUI
*,
Takeo S
UGIYAMA
*, Tokuzou Y
OKOKAWA
*,
Yuji N
EMOTO
** and Fumihiko T
ANAKA
***
* Department of Radiology, ** Department of Ophthalmology, *** Department of Surgical Pathology,
Teikyo University School of Medicine
A 67-year-old man was hospitalized at our institu-
tion complaining with epiphora and exophthalmos on
the left side. Magnetic resonance imaging (MRI)
showed an ill demarcated retrobulbar mass in the left
orbit.
67
Ga scintigraphy revealed avid uptake in the
left orbital region. The patient was treated with radia-
tion therapy. ...
[1907]
Crohn’s Disease associated lymphoma after treatment with inf ...
From [www.rila.co.uk] Last viewed: 13.07.2004
100
CME Gastroenterology 2001; 4(3):100-101
Rila Publications Ltd.
Crohn’s Disease associated lymphoma after
treatment with infliximab
Case Report
Abstract
Infliximab (antibody to tumour necrosis factor) has a
growing place in the management of refractory and
fistulating Crohn’s disease. Lymphoma has been associated
with the use of other immunomodulatory drugs but far from
unequivocally so when they are used in Crohn’s disease. A
case is described in which use of infliximab was followed by
the early presentation of an Epstein-Barr virus-associated
anaplastic lymphoma . The possible links between these
phenomena are discussed.
Keywords
Case report, Crohn’s disease, lymphoma , infliximab,
tumor necrosis factor.
Case report
A 25 year old female patient had developed
Crohn’s disease at the age of ...
[1908]
The Leukemia & Lymphoma Society’s
From [www.teamandrea.com] Last viewed: 13.07.2004
lymphoma
The Leukemia & Lymphoma Society?s
2004 Man & Woman of the Year Campaign
The Man & Woman of the Year Awards are part of a national campaign to raise money for the fight against blood cancers such as leukemia, lymphoma and myeloma. Hundreds of men and women in cities across America vie for the title each year.
The Leukemia & Lymphoma Society's National Capital Area Chapter will launch its 2004 Man & Woman of the Year campaign the week of April 5, 2004. The campaign will run for approximately 10 weeks, ending with a Grand Finale Gala on Friday, June 11, 2004, at the Four Seasons Hotel in Georgetown.
All candidates vying for the title of Man & Woman of the Year agree to utilize their leadership abilities to conduct their own fundraising campaigns for the Society. Every dollar counts as one vote. The top male and female candidates with the most votes are named ...
[1909]
Advanced Diffuse Histiocytic Lymphoma, a Potentially Curable ...
From [www.laskerfoundation.org] Last viewed: 13.07.2004
[1910]
Induction and Prevention of Virus-associated Malignant Lymphoma by ...
From [www.lib.okayama-u.ac.jp] Last viewed: 13.07.2004
Induction and Prevention of Virus-associated Malignant
Lymphoma by Serial Transmission of EBV-related Virus
from Cynomolgus by Blood Transfusion in Rabbits
Tirtha Raj Koirala , Kazuhiko Hayashi , Zaishun Jin , Sachiyo Onoda ,
Takehiro Tanaka , Wakako Oda , Koichi Ichimura , Nobuya Ohara ,
Takashi Oka , Masao Yamada , and Tadashi Yoshino
Department of Pathology, Department of Virology, Okayama University Graduate School of Medicine and Dentistry,
Okayama 700-8558, Japan, and Division of Molecular Pathology, Department of Microbiology and Pathology,
Tottori University Faculty of Medicine, Yonago 683-8503, Japan
Epstein-Barr virus (EBV)-related herpesvirus (Si-IIA-EBV)was serially transmitted for 3 passages
from rabbit to rabbit of the opposite sex by blood transfusion, which subsequently induced virus-
associated rabbit lymphomas. The virus could be transmitted by transfusion with 15-20 ml of whole
blood ...